MedTrace Logo

Optimal End-Tidal (ET) Sevoflurane and Desflurane Concentration for Extubation of Supreme Laryngeal Mask Airway (LMA) in Adults

NCT01083953 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2015-12-03

No results posted yet for this study

Summary

The purpose of this study is to determine the optimal volatile anaesthetic (sevoflurane and desflurane) to remove a Supreme LMA in adults in which there is minimal airway response.

Null hypothesis: there is no significant difference between the optimal end tidal concentration of sevoflurane and desflurane for Supreme LMA removal.

Conditions

  • Airway Complications

Interventions

DRUG

Sevoflurane

Comparing the optimal end-tidal concentration sevoflurane and desflurane for LMA extubation

DRUG

Desflurane

Comparing the optimal end-tidal concentration sevoflurane and desflurane for LMA extubation

Sponsors & Collaborators

  • Malaysian Society of Anaesthesiologists

    collaborator OTHER

  • University of Malaya

    lead OTHER

Principal Investigators

  • Cindy Thomas Joseph · Department of Anaesthesiology, UMMC

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01083953 on ClinicalTrials.gov